GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $151,000 | +71.6% | 2,214 | -20.0% | 0.01% | +100.0% |
Q2 2022 | $88,000 | -8.3% | 2,769 | +0.4% | 0.00% | +50.0% |
Q1 2022 | $96,000 | +3.2% | 2,759 | -13.1% | 0.00% | 0.0% |
Q4 2021 | $93,000 | +13.4% | 3,175 | -1.6% | 0.00% | 0.0% |
Q3 2021 | $82,000 | -30.5% | 3,227 | -3.9% | 0.00% | 0.0% |
Q2 2021 | $118,000 | -13.9% | 3,357 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $137,000 | -26.3% | 3,357 | -21.9% | 0.00% | -25.0% |
Q4 2020 | $186,000 | -21.5% | 4,301 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $237,000 | -12.9% | 4,301 | 0.0% | 0.01% | -14.3% |
Q2 2020 | $272,000 | +21.4% | 4,301 | -1.9% | 0.01% | +16.7% |
Q1 2020 | $224,000 | -36.7% | 4,386 | -1.5% | 0.01% | -25.0% |
Q4 2019 | $354,000 | +59.5% | 4,453 | -2.9% | 0.01% | +60.0% |
Q3 2019 | $222,000 | -8.6% | 4,585 | -0.8% | 0.01% | 0.0% |
Q2 2019 | $243,000 | -2.8% | 4,624 | -2.2% | 0.01% | -16.7% |
Q1 2019 | $250,000 | – | 4,730 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |